http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA03011770-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
filingDate 2002-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba43f2a20737b2fac0439a8aea0c64f9
publicationDate 2004-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-PA03011770-A
titleOfInvention PROCESS FOR THE PREPARATION OF CITALOPRAM RACEMICO AND / OR S- OR R-CITALOPRAM BY SEPARATION OF A MIXTURE OF R- AND S-CITALOPRAM.
abstract The invention relates to a process for the preparation of racemic citalopram free base or an acid addition salt thereof and / or R- or S-citalopram as the free base or an acid addition salt thereof by separation of a mixture of R- and S-citalopram with more than 50% of one of the enantiomers in a fraction consisting of racemic citalopram and / or a fraction of S-citalopram or R-citalopram, characterized in that i) citalopram is precipitated in a solvent as the free base or as an acid addition salt thereof; ii) the precipitate formed is separated from the mother liquor; iia) if the precipitate is crystalline it is optionally recrystallized one or more times to form racemic citalopram, and then optionally converted into an acid addition salt thereof; iib) if the precipitate is not crystalline, steps i) and ii) are repeated, optionally, until a crystalline precipitate is obtained and the crystalline precipitate is recrystallized one or more times to form racemic citalopram and then optionally converted into a salt of addition of the acid thereof; iii) the mother liquor is optionally subjected to further purification and is isolated S-citalopram or R-citalopram from the mother liquor and optionally converted into an acid addition salt thereof.
priorityDate 2001-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29922413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426266256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575380

Total number of triples: 25.